← Leaderboards
Vernon K. Sondak
University Of Michigan At Ann Arbor
$499,486
Attributed
$499,486
Total exposure
4
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $1.8M · FY2006–17$2M$1.5M$1M$500K$0
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
Funding mix
By agency
NIH$5,669,877 · 5
By mechanism
P50$5,448,816 · 2
U10$220,855 · 1
M01$206 · 2
Top collaborators
No co-investigators on record.
Others in their field
Top investigators on “Malignant Neoplasms”
- David Heimbrook · Leidos Biomedical Research, Inc.$1,074,554,219
- Leonard Freedman · Leidos Biomedical Research, Inc.$527,106,485
- Ethan Dmitrovsky · Leidos Biomedical Research, Inc.$357,875,933
- Richard K. Wilson · Washington University$274,272,747
- Larry Arthur$223,443,122
- Lynn Briscoe · Leidos Biomedical Research, Inc.$186,892,879
Research focus
Malignant NeoplasmsOncologyPreventionCutaneousBaseInnovationResearch PersonnelLeadProgramsSuccessSkinSkin CancerCollaborationsFloridaPrincipal InvestigatorGrantPilot ProjectsProgram Research Project GrantsEvaluationMelanomaLeadershipLungMemberBasic Science
Grant awards (15)
Moffitt Skin Cancer SPORE$1,789,062
P50 · FY2017 · CA · contact PI
Developmental Research Program$60,137
P50 · FY2017 · CA · contact PI
Moffitt Skin Cancer SPORE$1,681,718
P50 · FY2016 · CA · contact PI
Developmental Research Program$48,567
P50 · FY2016 · CA · contact PI
Moffitt Skin Cancer SPORE$1,699,611
P50 · FY2015 · CA · contact PI
Developmental Research Program$56,663
P50 · FY2015 · CA · contact PI
Developmental Research Program$56,654
P50 · FY2014 · CA · contact PI
Developmental Research Program$56,404
P50 · FY2013 · CA · contact PI
SWOG Institutional Grant$1
U10 · FY2008 · CA · contact PI
SWOG Institutional Grant$1
U10 · FY2007 · CA · contact PI
SWOG Institutional Grant$220,853
U10 · FY2006 · CA · contact PI
MELANOMA VACCINE--TYROSINASE/GP100 W/ MONTANIDE ISA51 OR GM CSF$0
M01 · FY2002 · RR
ADOPTIVE CELL THERAPY OF SOFT TISSUE SARCOMAS USING AUTOLOGOUS TUMOR VACCINATION$0
M01 · FY2002 · RR
MELANOMA VACCINE--TYROSINASE/GP100 W/ MONTANIDE ISA51 OR GM CSF$206
M01 · FY2000 · RR
ADOPTIVE CELL THERAPY OF SOFT TISSUE SARCOMAS USING AUTOLOGOUS TUMOR VACCINATION$0
M01 · FY2000 · RR